The Investment Framework for HIV/AIDS was published in The Lancet in June 2011 to guide the global response to HIV, and sets out a model for HIV investment and HIV programming for the next decade.
It is a framework that projects an increase in spending on HIV/AIDS leading up to 2015, followed by a decline in spending from 2015 to 2020.
For the first time, a model has been developed that can show a decline in the need for HIV programmes and services, as the effect of current and future targeted investments reach a tipping point. HIV investments, and HIV rates, decline.
Download our discussion paper ‘What is the Investment Framework for HIV/AIDS’ and what does it mean for the Alliance?’